All News

Dr. Gary Gibbons and Dr. Julie Panepinto
|
News Release
FDA approval of gene therapies for sickle cell disease: Q&A with NHLBI Director Dr. Gary Gibbons and NHLBI’s Division of Blood Diseases and Resources Director Dr. Julie Panepinto
The U.S. Food and Drug Administration approved two new gene therapies to treat sickle cell disease — one a gene-editing and the other a gene-addition approach. Nearly 100,000 people in the United States — and millions worldwide — have been diagnosed with this painful, life-threatening genetic blood disease. To help explain the historic importance...
Filter by keyword

ADD OTHER FILTERS

Filter by

News Type
Topic
Language
Published Date

Filter by News Type

Done

Filter by Topic

Done

Filter by Language

Done

Filter by Published Date

Done
Showing 3 out of 273 results
We couldn't find any matches